The U.S. Food and Drug Administration (FDA) has approved Saphris tablets (asenapine) to treat adults with schizophrenia or bipolar disorder.
"Mental illnesses like schizophrenia and bipolar disorder can be ...
Last week, the U.S. Food and Drug Administration (FDA) handed down two new approvals for Invega (paliperidone), an atypical antipsychotic medication, for the treatment of schizoaffective disorder, and ...
A once-daily form of trazodone, a second-generation antidepressant that has been available for the treatment of depression for decades, has been rejected by the U.S. Food ...
The U.S. Food and Drug Administration today announced that it is requiring manufacturers to put a Boxed Warning on the prescribing information for the smoking ...
The U.S. Food and Drug Administration (FDA) urged caution on interpreting the findings from a new study published on Monday that showed an increase in ...
Three atypical antipsychotics -- Seroqiel, Geodon, and Zyprexa -- were voted to be “acceptably safe” and effective for the treatment of schizophrenia ...
Seroquel was voted to be "acceptably safe" and effective for the treatment of schizophrenia in teenagers, said a U.S. Food and Drug Administration (FDA) panel of outside ...
A review of a government decision to issue a warning for children taking antidepressants suggests unintended consequences.
Government warnings about suicidality among children taking antidepressants appear to be associated with ...
Risperdal Consta (risperidone), a drug already approved in the treatment of schizophrenia, has received approval by the U.S. Food and Drug Administration (FDA) for the treatment of bipolar I disorder. ...
The U.S. Food and Drug Administration (FDA) yesterday approved a new psychiatric medication for the treatment of adults with schizophrenia called Fanapt (iloperidone).
Fanapt (iloperidone) is a mixed dopamine ...
Copyright © 1992-2012 Psych Central. All rights reserved.
Site last updated: 26 May 2012
|
